2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial)
- 28 June 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 58 (1), 11-18
- https://doi.org/10.1016/j.jacc.2011.02.023
Abstract
No abstract availableKeywords
Funding Information
- Abbott Vascular
- Boston Scientific
This publication has 12 references indexed in Scilit:
- Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents: 2-Year Follow-Up From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV TrialJournal of the American College of Cardiology, 2011
- Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II studyEuroIntervention, 2010
- The Unrestricted Use of Sirolimus- and Paclitaxel-Eluting Stents Results in Better Clinical Outcomes During 6-Year Follow-Up Than Bare-Metal Stents: An Analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus–Stent Evaluated At Rotterdam Cardiology Hospital) RegistriesJACC: Cardiovascular Interventions, 2010
- Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery DiseaseNew England Journal of Medicine, 2010
- Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trialsEuropean Heart Journal, 2010
- Novel Polymeric Coatings with the Potential to Control In-stent Restenosis — An In Vitro StudyJournal of Biomaterials Applications, 2008
- Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice: 4-Year Results From a Large 2-Institutional Cohort StudyJournal of the American College of Cardiology, 2008
- Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting StentsJournal of the American College of Cardiology, 2008
- Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery DiseaseJama-Journal Of The American Medical Association, 2008
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007